Your browser doesn't support javascript.
loading
A reply to "Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model".
Moldaver, Daniel; Hurry, Manjusha; Evans, William K; Cheema, Parneet K; Sangha, Randeep; Burkes, Ronald; Melosky, Barbara; Tran, Diana; Boehm, Darryl; Venkatesh, Jaya; Walisser, Susan; Orava, Erik; Grima, Daniel.
Afiliação
  • Moldaver D; Cornerstone Research Group, Burlington, Ontario, Canada.
  • Hurry M; AstraZeneca Canada, Mississauga, Ontario, Canada.
  • Evans WK; McMaster University, Hamilton, Ontario, Canada.
  • Cheema PK; William Osler Health System, Brampton, Ontario, Canada.
  • Sangha R; Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Burkes R; Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Melosky B; BC Cancer, Vancouver, British Columbia, Canada.
  • Tran D; Eversana Life Sciences Services, Burlington, Ontario, Canada.
  • Boehm D; Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada.
  • Venkatesh J; Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada.
  • Walisser S; BC Cancer, Vancouver, British Columbia, Canada.
  • Orava E; AstraZeneca Canada, Mississauga, Ontario, Canada.
  • Grima D; Eversana Life Sciences Services, Burlington, Ontario, Canada. Electronic address: daniel.grima@eversana.com.
Lung Cancer ; 151: 110-111, 2021 01.
Article em En | MEDLINE | ID: mdl-33323299

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article